Will the FDA approve a cure for Type 1 Diabetes before 2033?
Price history — Will the FDA approve a cure for Type 1 Diabetes before 2033?
Last 7 days of market NO price (blue) with the fair-price range (orange).
━ market YES▬ fair range
Market price
YES34¢ (34%)
NO66¢ (66%)
Latest refresh · prices in cents
Kalshi • Volume: 8.4K contracts • Updated 3h agoCloses: 2033-01-01
Kalshi · Health
OU's Pick
NO at 66¢ · pays 1.5×
Price gap
Kalshi66¢
→OU's fair85¢
+19¢ underpriced · pays 1.5×
Confidence
Moderate
Recent FDA approvals for Lantidra and Tzield focus on cellular therapy and delaying onset rather than a definitive cure for Type 1 Diabetes.
Wide edge+19¢
Not financial advice. For informational purposes only. Prediction markets involve risk of loss. AI may contain errors.